These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2214246)

  • 1. Detection of early visual field change in ocular hypertension using STATPAC.
    Park HJ; Kim DM; Youn DH; Hong C
    Korean J Ophthalmol; 1990 Jun; 4(1):16-22. PubMed ID: 2214246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Visual Field Measurement with Heidelberg Edge Perimeter and Humphrey Visual Field Analyzer in Patients with Ocular Hypertension.
    Kaczorowski K; Mulak M; Szumny D; Baranowska M; Jakubaszko-Jabłońska J; Misiuk-Hojło M
    Adv Clin Exp Med; 2016; 25(5):937-944. PubMed ID: 28028959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Perimetry with a glaucoma-specific test grid. A clinical study with the GG program].
    Roesen B; Gramer E
    Ophthalmologe; 1995 Aug; 92(4):564-73. PubMed ID: 7549349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of glaucomatous visual field defect using a screening program of Humphrey Field Analyzer.
    Hong C; Song KY; Youn DH; Park WH
    Korean J Ophthalmol; 1990 Jun; 4(1):23-5. PubMed ID: 2214247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the OKP visual field screening test with the Humphrey field analyser.
    Vernon SA; Quigley HA
    Eye (Lond); 1992; 6 ( Pt 5)():521-4. PubMed ID: 1286719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline visual field characteristics in the ocular hypertension treatment study.
    Johnson CA; Keltner JL; Cello KE; Edwards M; Kass MA; Gordon MO; Budenz DL; Gaasterland DE; Werner E;
    Ophthalmology; 2002 Mar; 109(3):432-7. PubMed ID: 11874743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similarities between the visual fields of ocular hypertensive and normal eyes.
    Katz J; Sommer A
    Arch Ophthalmol; 1986 Nov; 104(11):1648-51. PubMed ID: 3778281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter comparison study of the Humphrey Field Analyzer I and the Humphrey Field Analyzer II.
    Johnson CA; Cioffi GA; Drance SM; Gaasterland D; Mills RP; Ashburn F; Hnik P; Van Coevorden RE
    Ophthalmology; 1997 Nov; 104(11):1910-7. PubMed ID: 9373125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of Goldmann applanation tonometry on automated static threshold perimetry.
    Ruben JB; Lewis RA; Johnson CA; Adams C
    Ophthalmology; 1988 Feb; 95(2):267-70. PubMed ID: 2902545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining progressive visual field loss in serial Humphrey visual fields.
    Birch MK; Wishart PK; O'Donnell NP
    Ophthalmology; 1995 Aug; 102(8):1227-34; discussion 1234-5. PubMed ID: 9097752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Static versus kinetic testing in the nasal peripheral field in patients with glaucoma.
    Stewart WC
    Acta Ophthalmol (Copenh); 1992 Feb; 70(1):79-84. PubMed ID: 1557979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of early glaucomatous progression with octopus cluster trend analysis.
    Naghizadeh F; Holló G
    J Glaucoma; 2014; 23(5):269-75. PubMed ID: 24892507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognizing glaucomatous field loss with the Humphrey STATPAC.
    Enger C; Sommer A
    Arch Ophthalmol; 1987 Oct; 105(10):1355-7. PubMed ID: 3662906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Distribution of retinal sensitivity with blue on yellow perimetry in ocular hypertension].
    Maeda H; Tanaka Y; Sugiura T; Nakamura M; Yamamoto M
    Nippon Ganka Gakkai Zasshi; 1998 Feb; 102(2):111-6. PubMed ID: 9513357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Static threshold visual field in glaucoma with the Fastpac algorithm of the Humphrey Field Analyser. Is the gain in examination time offset by any loss of information?
    Nordmann JP; Denis P; Nguer Y; Mouton-Chopin D; Saraux H
    Eur J Ophthalmol; 1994; 4(2):105-10. PubMed ID: 7950333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blue versus white stimuli in ocular hypertension with the Friedmann Mark 1 Visual Field Analyser.
    Hugkulstone CE; Vernon SA
    Eye (Lond); 1992; 6 ( Pt 4)():356-60. PubMed ID: 1478305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual function-specific perimetry for indirect comparison of different ganglion cell populations in glaucoma.
    Sample PA; Bosworth CF; Blumenthal EZ; Girkin C; Weinreb RN
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1783-90. PubMed ID: 10845599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of weighting the "mean defect" visual field index according to threshold variability in the central and midperipheral visual field.
    Funkhouser A; Fankhauser F
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(3):228-31. PubMed ID: 1869056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of the G1 and Octosmart programs in detecting temporal changes in the visual field.
    Fankhauser F; Gloor B; Iliev M; Kalman A
    Int Ophthalmol; 1997-1998; 21(6):311-7. PubMed ID: 9869338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual field damage proximal to fixation in normal- and high-tension glaucoma eyes.
    Koseki N; Araie M; Suzuki Y; Yamagami J
    Jpn J Ophthalmol; 1995; 39(3):274-83. PubMed ID: 8577079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.